Algernon Announces Patients Requested Ongoing Supply of Ifenprodil after IPF and Chronic Cough Phase 2 Study Ended
June 21, 2022 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...
NCPA Cheers FTC Probe of PBMs: Huge Win for Consumers, Pharmacies
June 07, 2022 14:19 ET
|
National Community Pharmacists Association
Alexandria, Va., June 07, 2022 (GLOBE NEWSWIRE) -- The National Community Pharmacists Association is hailing a move by the Federal Trade Commission to proceed with a 6(b) study of pharmacy benefit...
NCPA Strongly Supports Senate Bill Empowering FTC Action Against PBMs
May 24, 2022 14:05 ET
|
National Community Pharmacists Association
Alexandria, Va., May 24, 2022 (GLOBE NEWSWIRE) -- The National Community Pharmacists Association is strongly supporting the Pharmacy Benefit Manager Transparency Act, new legislation introduced...
NCPA Reveals Resource to Streamline Reporting of State PBM Law Violations
May 10, 2022 11:30 ET
|
National Community Pharmacists Association
Alexandria, Va., May 10, 2022 (GLOBE NEWSWIRE) -- With virtually every state having enacted some type of pharmacy benefit manager regulation, ensuring that these policies are actually being enforced...
SECU Foundation Announces $1.5 Million Commitment for New Hospice Initiative in Boone
March 14, 2022 17:26 ET
|
State Employees' Credit Union (SECU)
RALEIGH, N.C., March 14, 2022 (GLOBE NEWSWIRE) -- SECU Foundation has announced a significant grant of $1.5 million to AMOREM, the recent integration of Caldwell Hospice and Palliative Care and...
NCPA Analysis Sinks Broken-Record Argument Against PBM Regulations
March 14, 2022 14:45 ET
|
National Community Pharmacists Association
Alexandria, Va., March 14, 2022 (GLOBE NEWSWIRE) -- “Premiums will go up! Premiums will go up!” It’s what pharmacy benefit manager lobbyists squeal every time there’s a bill to regulate PBMs....
Hardy Diagnostics Now Offers the BioCode® MDx-3000
March 14, 2022 07:00 ET
|
Hardy Diagnostics
SANTA MARIA, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- Hardy Diagnostics, a leader in manufactured and distributed microbiology products, is pleased to announce it is now the exclusive distributor...
By 2028, Global Demand for Digital Therapeutics Market Will Surpass USD 14.52 Billion at 28.1% CAGR Growth: Says Vantage Market Research
February 28, 2022 04:00 ET
|
Vantage Market Research
WASHINGTON, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Digital Therapeutics Market finds that the increasing incidence of preventable chronic diseases...
NHF Calls on Congress and Federal Agencies to Conduct Oversight Of Current Care Models for Migraine Patients
February 03, 2022 14:44 ET
|
National Headache Foundation
Chicago, IL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Tom Dabertin, Chief Executive Officer/Executive Director of the National Headache Foundation (NHF) is calling on members of Congress and regulatory...
DAXOR ANNOUNCES KEY MILESTONES ACHIEVED FOR MULTICENTER BVA-100® STUDY IN HOSPITALIZED PATIENTS WITH COVID-19
January 05, 2022 08:00 ET
|
Daxor Corporation
Patient Enrollment Complete and Data Analysis Commences with Daxor’s Blood Volume Analysis Technology Oak Ridge, TN, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the...